N-(6-aminohexyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid
Structure Info
- Chemspace ID
- CSSB00159265600 (In-Stock Building Blocks)
- CAS
- 1950635-14-9
- MFCD
- MFCD31715439
- IUPAC Name
- N-(6-aminohexyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid
- Mol formula
- C23H27F3N4O8
- Mol weight
- 544 Da
- Catalog Number(s)
- A1148142, AA01EO6Y, ACAEOG459, ADD63514, AG-20577, AG01EO9Q, AP13023, AR01EOYQ, AT18335, AT18335-0.1G, AT18335-0.25G, AX64054, B2693-008754, BBLS00159265600, BD01107044, BF64054, BUP12943, CS-0058449, CSC159265600, EC01EQFI, EN300-7489804, F986833, HY-112618A, M26948, PR1950635149, ST01EPQI, T17919, TX01EPFE, X211453, Y1266855, Y4247191, ZB1949, ZXC201477, bbls00159265600
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -0.74
- Heavy atoms count
- 38
- Rotatable bond count
- 11
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.478
- Polar surface area (Å)
- 148
- Hydrogen bond acceptors count
- 7
- Hydrogen bond donors count
- 3
![Chemical structure of N-(6-aminohexyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid (C23H27F3N4O8) - CSSB00159265600](/st/structure/200/0779da0f4940b74d087c370bc5c56669/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCCCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png "C23H27F3N4O8")
- Zoom the structure
- CSSB00159265600
Items Overall 63 items from 19 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific LLC | 3 days | United States To: | 97 | 50 mg | 179.30 | |
| 1st Scientific LLC | 3 days | United States To: | 97 | 100 mg | 302.50 | |
Description: Thalidomide-O-amido-C6-NH2 (TFA); CAS: 1950635-14-9 | ||||||
| ChemScene CN | 5 days | China To: | 97 | 50 mg | 139.00 | |
| ChemScene CN | 5 days | China To: | 97 | 100 mg | 257.00 | |
| ChemScene CN | 5 days | China To: | 97 | 500 mg | 1,284.00 | |
| ChemScene CN | 5 days | China To: | 97 | 1 g | 1,427.00 | |
| ChemScene CN | 5 days | China To: | 97 | 2 g | 2,853.00 | |
Description: Thalidomide-O-amido-C6-NH2 (TFA); CAS: 1950635-14-9 | ||||||
| AiFChem | 5 days | United States To: | 95 | 100 mg | 221.00 | |
| AiFChem | 5 days | United States To: | 95 | 250 mg | 509.00 | |
| AiFChem | 5 days | United States To: | 95 | 1 g | 1,224.00 | |
Description: N-(6-Aminohexyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; Hazard statement: H301, H312, H361; CAS: 1950635-14-9 | ||||||
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 50 mg | 125.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 100 mg | 231.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 250 mg | 534.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 1 g | 1,284.00 | |
Description: Name:N-(6-Aminohexyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; Hazard statement: 6.1; CAS: 1950635-14-9 | ||||||
| Angene International Limited | 10 days | China To: | 95 | 50 mg | 97.20 | |
| Angene International Limited | 10 days | China To: | 95 | 100 mg | 160.20 | |
| Angene International Limited | 10 days | China To: | 95 | 250 mg | 395.10 | |
| Angene International Limited | 10 days | China To: | 95 | 500 mg | 751.50 | |
| Angene International Limited | 10 days | China To: | 95 | 1 g | 981.00 | |
Description: N-(6-Aminohexyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; CAS: 1950635-14-9 | ||||||
| AiFChem CN | 10 days | China To: | 95 | 50 mg | 120.00 | |
Description: N-(6-Aminohexyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; Hazard statement: H301, H312, H361; CAS: 1950635-14-9 | ||||||
| Advanced ChemBlocks CN | 10 days | China To: | 98 | 100 mg | 330.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 98 | 250 mg | 740.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 98 | 1 g | 1,830.00 | |
Description: Thalidomide-O-amido-C6-NH2 (TFA); CAS: 1950635-14-9 | ||||||
| Astatech CN | 10 days | China To: | 95 | 100 mg | 764.50 | |
| Astatech CN | 10 days | China To: | 95 | 250 mg | 1,529.00 | |
Description: THALIDOMIDE-O-AMIDO-C6-NH2 (TFA); CAS: 1950635-14-9 | ||||||
| A2B Chem | 12 days | United States To: | 95 | 10 mg | 34.50 | |
| A2B Chem | 12 days | United States To: | 95 | 25 mg | 55.20 | |
Description: Thalidomide-O-Amido-C6-NH2 (TFA); CAS: 1950635-14-9 | ||||||
| AA BLOCKS | 12 days | United States To: | 90 | 10 mg | 58.30 | |
| AA BLOCKS | 12 days | United States To: | 90 | 25 mg | 79.20 | |
| AA BLOCKS | 12 days | United States To: | 90 | 50 mg | 145.20 | |
| AA BLOCKS | 12 days | United States To: | 90 | 100 mg | 267.30 | |
Description: N-(6-Aminohexyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; CAS: 1950635-14-9 | ||||||
| Ambeed CN | 12 days | China To: | 95 | 50 mg | 112.50 | |
| Ambeed CN | 12 days | China To: | 95 | 100 mg | 207.90 | |
| Ambeed CN | 12 days | China To: | 95 | 250 mg | 480.60 | |
| Ambeed CN | 12 days | China To: | 95 | 1 g | 1,155.60 | |
Description: Name: Thalidomide-O-amido-C6-NH2 TFA; Hazard statement: 6.1; CAS: 1950635-14-9 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 50 mg | 154.10 | |
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 100 mg | 255.30 | |
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 250 mg | 638.25 | |
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 1 g | 1,588.15 | |
| Fluorochem CN | 14 days | China To: | 97 | 50 mg | 174.00 | |
| Fluorochem CN | 14 days | China To: | 97 | 100 mg | 320.00 | |
| Fluorochem CN | 14 days | China To: | 97 | 500 mg | 1,533.00 | |
| Fluorochem CN | 14 days | China To: | 97 | 1 g | 1,703.00 | |
| Fluorochem CN | 14 days | China To: | 97 | 2 g | 3,405.00 | |
Description: Thalidomide-O-amido-C6-NH2 (TFA); ; Storage Conditions: ambient storage; Hazard Codes: H302, H315, H319, H335; GHS Pictograms: GHS07; CAS: 1950635-14-9 | ||||||
| BB4LS GS | 15 days | Germany To: | 95 | 50 umol | 112.59 | |
| BB4LS GS | 15 days | Germany To: | 95 | 100 umol | 212.03 | |
| BB4LS GS | 15 days | Germany To: | 95 | 200 umol | 215.88 | |
| BB4LS GS | 15 days | Germany To: | 95 | 300 umol | 507.01 | |
| BB4LS GS | 15 days | Germany To: | 95 | 500 umol | 515.91 | |
| ChemScene LLC | 15 days | United States To: | 97 | 50 mg | 139.00 | |
| ChemScene LLC | 15 days | United States To: | 97 | 100 mg | 257.00 | |
Description: Thalidomide-O-amido-C6-NH2 (TFA); CAS: 1950635-14-9 | ||||||
| eNovation CN | 20 days | China To: | 95 | 50 mg | 115.00 | |
| eNovation CN | 20 days | China To: | 95 | 100 mg | 178.25 | |
| eNovation CN | 20 days | China To: | 95 | 250 mg | 391.00 | |
| eNovation CN | 20 days | China To: | 95 | 1 g | 943.00 | |
Description: N-(6-Aminohexyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate; CAS: 1950635-14-9 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 95 | 50 mg | 149.60 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 100 mg | 248.60 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 250 mg | 616.00 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 500 mg | 1,229.80 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 1 g | 1,526.80 | |
Description: Thalidomide-O-Amido-C6-NH2 (TFA); CAS: 1950635-14-9 | ||||||
| BOC Sciences | 24 days | United States To: | 90 | 100 mg | 482.90 | |
Description: CAS: 1950635-14-9 | ||||||
| 10X CHEM | TBD | United States To: | 90 | 10 mg | 27.50 | |
| 10X CHEM | TBD | United States To: | 90 | 25 mg | 44.00 | |
Description: Thalidomide-O-Amido-C6-NH2 (TFA); CAS: 1950635-14-9 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-(8-aminooctyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB00138413550](/st/structure/200/4dcef927bc48275aabee172de1aeb952/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCCCCCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of N-(5-aminopentyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB06256034978](/st/structure/200/35390d0689be73738f81aae170907b64/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCCCNC%2528%253DO%2529COc1cccc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c12.png)
![Chemical structure of N-(4-aminobutyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB00138413549](/st/structure/200/805463e9389402f7a1d5bedfda2a7121/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of N-(3-aminopropyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB00161188928](/st/structure/200/629817e50df8aa162fa0ab07e1551908/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of N-(3-{2-[2-(3-aminopropoxy)ethoxy]ethoxy}propyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB03437847026](/st/structure/200/65a46124d0fa428123cada7cea69155c/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCOCCOCCOCCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of N-(2-{2-[2-(2-aminoethoxy)ethoxy]ethoxy}ethyl)-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB00161188577](/st/structure/200/d448481d1b3776eb54f1a5a6e2608601/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCOCCOCCOCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of N-[2-(2-aminoethoxy)ethyl]-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide; trifluoroacetic acid - CSSB20561580115](/st/structure/200/3116b85208a803dc7ca009254eba856d/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCOCCNC%2528%253DO%2529COC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
